News summary

Hyaluronic acid–functionalized synergistic nanostructured lipid carriers for sustained release and enhanced bioavailability

Source: Nature - Biotechnology • Published: 31 Oct 2026, 00:00

Summarized by Masters of Longevity from Nature - Biotechnology.

Hyaluronic-acid coated nanostructured lipid carriers showed sustained release and higher bioavailability in breast cancer models.

Hyaluronic acid–functionalized synergistic nanostructured lipid carriers for sustained release and enhanced bioavailability
Key Takeaways
  • HA-TMX-LTZ-NLCs showed sustained drug release in vitro.
  • Co-loaded NLCs were more effective against MCF-7 cells.
  • Rat PK showed about fourfold increased systemic exposure.
Read the full article at Nature - Biotechnology ↗

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.